An update and future directions in advanced gastric or gastrointestinal junction cancer (G/GEJC)

被引：0
|
作者：
不详
机构：
来源：
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY | 2022年 / 15卷 / SUPPL 6期
关键词：
OPEN-LABEL;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：109 / 112
页数：4
相关论文
共 50 条
  • [31] An update on male breast cancer and future directions for research and treatment
    Berta, Sousa
    Elizabeth, Moser
    Fatiman, Cardoso
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2013, 717 (1-3) : 71 - 83
  • [32] Advanced Prostate Cancer: Treatment Advances and Future Directions
    Swami, Umang
    McFarland, Taylor R.
    Nussenzveig, Roberto
    Agarwal, Neeraj
    [J]. TRENDS IN CANCER, 2020, 6 (08): : 702 - 715
  • [33] Radiotheranostics in advanced prostate cancer: Current and future directions
    Jia, Angela Y. Y.
    Kiess, Ana P.
    Li, Qiubai
    Antonarakis, Emmanuel S.
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2024, 27 (01) : 11 - 21
  • [34] Current treatment and future directions for advanced pancreatic cancer
    Rothenberg, ML
    [J]. PANCREATIC CANCER: ADVANCES IN MOLECULAR PATHOLOGY, DIAGNOSIS & CLINICAL MANAGEMENT, 1998, : 157 - 164
  • [35] Phase Ib trial of cabozantinib (C) in combination with atezolizumab (A) in patients (pts) with advanced hepatocellular carcinoma (HCC), gastric or gastroesophageal junction cancer (GC/GEJC), or colorectal cancer (CRC).
    Spencer, Kristen Renee
    Ramsingh, Giridharan
    Mohamed, Nehal
    Pal, Sumanta K.
    Rimassa, Lorenza
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [36] Future directions in endocrine treatment of advanced breast cancer
    Bland, KI
    [J]. ANNALS OF SURGICAL ONCOLOGY, 1999, 6 (08) : 14S - 16S
  • [37] Radiotheranostics in advanced prostate cancer: Current and future directions
    Angela Y. Jia
    Ana P. Kiess
    Qiubai Li
    Emmanuel S. Antonarakis
    [J]. Prostate Cancer and Prostatic Diseases, 2024, 27 : 11 - 21
  • [38] Oxaliplatin for the treatment of advanced colorectal cancer: Future directions
    Ducreux, M
    Louvet, C
    Bekradda, M
    Cvitkovic, E
    [J]. SEMINARS IN ONCOLOGY, 1998, 25 (02) : 47 - 53
  • [39] Current and future directions for the treatment of advanced thyroid cancer
    Prasongsook, Naiyarat
    [J]. ANNALS OF ONCOLOGY, 2019, 30 : 70 - 70
  • [40] Safety, tolerability, and preliminary antitumor activity of sitravatinib plus tislelizumab (TIS) in patients (pts) with unresectable locally advanced or metastatic gastric cancer/gastroesophageal junction cancer (GC/GEJC)
    Chen, Zhendong
    Bai, Yuxian
    Zhang, Tao
    Ying, Jieer
    Lin, Xiaoyan
    Yang, Liu
    Wang, Jun
    Zhang, Juan
    Yu, Fan
    Fei, Cong
    Huang, Ruiqi
    Li, Jin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
12345